Pilgrim Global buys Sable Offshore (SOC) shares worth $14.7m
Harvard Apparatus Regenerative Technology (NASDAQ:HRGN), a $34 million market cap company, saw CEO He Junli purchase 11,225 shares of common stock between September 2, 2025 and September 22, 2025, in multiple transactions at a weighted average price of $1.85 per share, for a total value of $20,766. The stock, which InvestingPro analysis shows is currently trading below its Fair Value, has gained over 20% in the past week.
Following the transaction, He Junli directly owns 277,275 shares of Harvard Apparatus Regenerative Technology. InvestingPro data reveals the company’s stock typically moves counter to market trends with a beta of -0.31. Subscribers can access 8 additional ProTips and comprehensive insider trading analysis on the platform.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.